Industrial Automation in Life Sciences

Industrial Automation in Life Sciences Market Outlook

The global Industrial Automation in Life Sciences market is poised to reach a staggering USD 12.5 billion by 2035, with an impressive compound annual growth rate (CAGR) of approximately 9.2% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing need for efficiency and accuracy in laboratory processes, particularly in drug discovery and clinical diagnostics, where the demand for precision is paramount. Furthermore, the rise of personalized medicine is driving the adoption of advanced automation technologies that can handle complex biological data rapidly and accurately. Alongside this, the growing trends toward high-throughput screening and the integration of artificial intelligence in laboratory automation are further propelling the market's expansion. The convergence of automation technologies with life sciences is fostering innovative solutions that optimize productivity and enhance research outcomes, creating a robust environment for market growth.

Growth Factor of the Market

The growth of the Industrial Automation in Life Sciences market is primarily driven by several interlinked factors that enhance the efficiency and efficacy of laboratory processes. Firstly, the rising demand for biopharmaceuticals and the increasing complexity of drug development processes necessitate advanced automation solutions to streamline workflows and minimize human error. Additionally, the heightened focus on regulatory compliance in life sciences demands more reliable and reproducible results, which automation can provide. Moreover, the growing popularity of personalized medicine requires more data-driven approaches, which can be effectively managed through automated systems. The surge in investments for research and development in the life sciences sector is also fostering the adoption of automated systems. Lastly, the ongoing digital transformation in healthcare emphasizes the need for integrated automation solutions that can support big data analytics and artificial intelligence applications.

Key Highlights of the Market

• The market is expected to reach USD 12.5 billion by 2035, growing at a CAGR of 9.2%.
• Increased focus on personalized medicine driving demand for advanced automation technologies.
• Rising investments in biopharmaceutical research amplifying the need for automation.
• Technological advancements in robotics and machine learning enhancing laboratory efficiency.
• Growing regulatory compliance demands leading to adoption of reliable automated systems.

By Product Type

Automated Liquid Handling Systems:

Automated Liquid Handling Systems are critical components in laboratory automation, designed to minimize human intervention in repetitive tasks such as pipetting and sample preparation. These systems enhance precision and accuracy while significantly speeding up workflows, which are essential in high-throughput environments. By employing sophisticated robotics and software control, these systems can handle multiple samples simultaneously, ensuring consistency and reliability in the results. The increasing demand for high-throughput screening applications in drug discovery is propelling the growth of this segment, as researchers seek to test large numbers of compounds efficiently. As laboratories adopt smaller and more compact formats, Automated Liquid Handling Systems are becoming more versatile, enabling their use in various applications, including genomics and proteomics, thus driving further market expansion.

Robotics and Machine Learning Systems:

The integration of Robotics and Machine Learning Systems in life sciences is revolutionizing laboratory processes by combining physical automation with intelligent data analysis. These systems facilitate complex tasks such as specimen sorting, data collection, and analysis without human oversight, leading to enhanced productivity and accuracy. Machine learning algorithms can analyze vast datasets generated from experiments, providing insights that inform decision-making and streamline research workflows. As the demand for precision medicine grows, laboratories are increasingly adopting these automated systems to keep pace with data generation and analysis needs. Moreover, advancements in artificial intelligence are significantly improving the capabilities of robotic systems, allowing them to adapt to new protocols and workflows, which enhances operational flexibility and reduces time-to-results.

Automated Microplate Readers:

Automated Microplate Readers are pivotal in numerous assays and high-throughput screening applications, allowing researchers to analyze multiple samples rapidly and efficiently. These devices are designed to perform various optical measurements, such as absorbance, fluorescence, and luminescence, providing critical data in drug discovery and diagnostics. The automation involved in these systems minimizes human error and improves reproducibility, which is essential for regulatory compliance in life sciences. Additionally, the integration of advanced detection technologies and software analytics with automated microplate readers enhances their functionality, enabling them to handle diverse assays and complex workflows. The increasing reliance on high-throughput methods in laboratories is driving the demand for these systems, facilitating faster and more accurate research outcomes.

Automated Storage and Retrieval Systems:

Automated Storage and Retrieval Systems (AS/RS) play a vital role in laboratory automation by optimizing the management of samples, reagents, and equipment. These systems are designed to store large volumes of items in a compact and organized manner while providing quick access for retrieval, which is crucial in fast-paced research environments. AS/RS technologies reduce the risk of sample degradation and loss by maintaining optimal storage conditions and improving inventory management. With the growing emphasis on data integrity and traceability in the life sciences sector, the demand for automated storage solutions is on the rise. Furthermore, the integration of AS/RS with laboratory information management systems (LIMS) enhances operational efficiency and supports seamless workflow automation, further catalyzing market growth.

Others:

This category encompasses various other automation products that contribute to enhanced laboratory efficiency and effectiveness. Innovations in packaging solutions, workflow management tools, and ancillary laboratory automation systems are included here. These products often complement the primary automation systems by providing essential support functions, such as sample tracking, data management, and instrument interfacing. The growing trend towards integrated laboratory solutions is propelling the demand for these ancillary products, as laboratories seek to create cohesive systems that maximize automation benefits. As the life sciences industry continues to evolve, the integration of new technologies, such as IoT and cloud computing, into these products is expected to further enhance their functionality and appeal.

By Application

Drug Discovery:

The application of industrial automation in drug discovery is transforming how new therapeutics are developed, facilitating faster and more efficient research processes. Automation technologies streamline the screening of compound libraries, enabling researchers to identify potential drug candidates at unprecedented speeds. By minimizing human error and increasing throughput, automated systems significantly enhance the reproducibility of experimental results, which is critical for regulatory submissions. Additionally, automation allows for the integration of complex experimental designs and high-throughput screening, which are essential in identifying novel compounds. As the pharmaceutical industry faces pressure to reduce development timelines and costs, the adoption of automation in drug discovery is expected to continue to grow, driving innovation and accelerating the availability of new therapies.

Clinical Diagnostics:

In clinical diagnostics, industrial automation plays a crucial role in enhancing the accuracy and efficiency of laboratory testing. Automated systems facilitate the processing of samples, from collection to analysis, ensuring that diagnostic results are delivered quickly and reliably. Automation reduces turnaround times, which is vital for patient care, especially in critical settings where timely results are essential for diagnosis and treatment decisions. Furthermore, the standardization of processes through automation minimizes variability and ensures compliance with stringent regulatory requirements. As the demand for rapid and accurate diagnostic testing continues to rise, driven by factors such as infectious disease outbreaks and personalized medicine, the market for automation in clinical diagnostics is expected to expand significantly.

Genomics:

The genomics application of industrial automation is revolutionizing the field by enabling the processing and analysis of large-scale genomic data with greater speed and accuracy. Automated systems streamline workflows for tasks such as DNA sequencing, sample preparation, and genotyping, reducing the time and labor associated with these processes. The growing availability of genomic data and advancements in sequencing technologies have led to an increased demand for automation solutions that can handle complex and voluminous datasets. Additionally, the integration of bioinformatics tools with automated systems allows for seamless data analysis and interpretation, enhancing the overall research output. As genomics continues to be pivotal in areas such as personalized medicine and genetic research, the automation market within this segment is expected to witness robust growth.

Proteomics:

Proteomics, the study of proteins and their functions, is significantly benefiting from advancements in industrial automation. Automation technologies facilitate high-throughput protein analysis and characterization, enabling researchers to handle large volumes of samples with precision and reproducibility. Automated systems aid in tasks such as liquid chromatography and mass spectrometry, which are essential for proteomic studies. The demand for proteomics is rising due to its applications in drug discovery, biomarker identification, and disease characterization. As researchers seek to gain deeper insights into protein functions and interactions, the adoption of automated solutions in proteomics is projected to grow, enabling more efficient and effective research outcomes.

Others:

This category includes various other applications that benefit from industrial automation in life sciences, such as environmental testing, food safety, and clinical research. Automation technologies enhance the efficiency of laboratory processes across these diverse applications by improving sample handling, data management, and analytical capabilities. As laboratories across different sectors strive for improved accuracy and productivity, the demand for automation solutions in these applications is expected to rise. The continuous evolution of automation technologies, including advances in robotics and software systems, is further enhancing their adaptability and scope of application across the life sciences landscape.

By Distribution Channel

Direct Sales:

The direct sales channel remains a prominent distribution mechanism for industrial automation solutions in life sciences. Manufacturers often engage directly with laboratories and research institutions to customize solutions that meet specific operational needs. This approach allows for personalized service and support, ensuring that customers receive tailored solutions that enhance their workflows. Additionally, direct sales enable manufacturers to cultivate strong relationships with their clients, fostering brand loyalty and repeat business. As direct engagement often leads to a deeper understanding of customer needs, the market for direct sales in industrial automation is likely to grow, providing insights that inform product development and innovation.

Distributor Sales:

Distributor sales serve as an essential channel for industrial automation in life sciences, offering manufacturers broad access to various markets and customer segments. Distributors typically have established networks and relationships within the scientific community, allowing them to effectively promote and distribute automation solutions. By leveraging the expertise and market knowledge of distributors, manufacturers can reach more customers, from small laboratories to large-scale research institutions. This channel is particularly beneficial for manufacturers looking to expand their market presence without incurring the costs associated with direct sales forces. The reliance on distributor sales is expected to continue growing as companies seek to capitalize on the extensive networks that distributors provide.

By Ingredient Type

Hardware:

The hardware segment of the industrial automation market encompasses a wide range of essential components, including robotics, sensors, and automated systems. This segment is vital as it forms the backbone of any automation solution, providing the physical means to execute tasks within laboratories. The demand for advanced hardware solutions is driven by the need for increased precision, reliability, and speed in laboratory processes. Innovations in hardware technologies, such as the miniaturization of devices and improvements in sensor capabilities, are further enhancing the functionality of automation systems. As laboratories continue to integrate automation into their workflows, the hardware segment is expected to experience robust growth, underpinning the overall market expansion.

Software:

The software component of industrial automation in life sciences is critical for enabling seamless operation and management of automated systems. This includes laboratory information management systems (LIMS), workflow management tools, and data analysis software that facilitate the integration of various laboratory processes. The growth of software solutions is driven by the increasing complexity of laboratory workflows, which necessitate sophisticated software for data tracking, process optimization, and regulatory compliance. As laboratories become more reliant on data-driven decision-making, the demand for advanced software solutions that can analyze and interpret large datasets is expected to rise, further fueling market growth. Moreover, the trend towards cloud-based software solutions is enhancing accessibility and collaboration within the life sciences sector.

Services:

Services related to industrial automation in life sciences encompass training, maintenance, and consulting, which are essential for optimizing the performance of automation systems. These services play a crucial role in ensuring that laboratories can effectively implement and utilize automated solutions to their fullest potential. The demand for support services is increasing as laboratories seek to enhance operational efficiency and minimize downtime associated with equipment failures or system updates. Additionally, the trend towards customized automation solutions necessitates advisory services to guide laboratories in selecting and integrating appropriate technologies. As the market for automation continues to grow, the importance of service offerings will become increasingly vital in supporting customers throughout the lifecycle of their automation solutions.

By Region

The Industrial Automation in Life Sciences market has exhibited dynamic growth across various regions, driven by technological advancements and increasing investments in the life sciences sector. North America, being at the forefront of technological innovation, holds the largest share of the market owing to the presence of established pharmaceutical and biotechnology companies. The region is expected to exhibit a CAGR of 9.5% during the forecast period, further solidifying its position as a leader in adopting automation technologies. The growing emphasis on research and development, coupled with favorable regulatory frameworks, has fostered a conducive environment for the expansion of industrial automation solutions in North America.

Europe follows closely, characterized by a strong focus on high-quality manufacturing and healthcare. The region's commitment to research and development, particularly in the biotech sector, has led to an increasing demand for automation solutions that enhance laboratory efficiency. The Asia Pacific region is anticipated to witness significant growth, driven by the rapid expansion of pharmaceutical and biotechnology sectors in countries like China and India. With the increasing adoption of automation technologies to improve productivity and meet the rising demand for healthcare services, the market in Asia Pacific is projected to grow robustly over the forecast period. Latin America and the Middle East & Africa are also emerging markets in industrial automation, benefitting from rising investments in healthcare and life sciences.

Opportunities

The Industrial Automation in Life Sciences market presents numerous opportunities for growth and innovation, particularly in the realm of personalized medicine. As the healthcare landscape shifts towards more individualized treatment options, there is a growing need for automation technologies that can manage complex datasets and streamline research workflows. Companies that invest in developing advanced automation solutions tailored for personalized medicine are likely to gain a competitive edge in this evolving market. Furthermore, the integration of artificial intelligence and machine learning into automation systems presents an opportunity to enhance data analysis and predictive capabilities, enabling laboratories to make informed decisions based on real-time insights. The continuous evolution of automation technologies also opens the door for collaborative partnerships between technology providers and life sciences organizations, fostering innovation and driving market growth.

Another promising opportunity lies in the increasing adoption of automated systems in emerging markets, where the demand for efficient laboratory processes is on the rise. As countries in Asia Pacific, Latin America, and Africa invest in healthcare infrastructure, there is a growing recognition of the importance of automation in improving laboratory efficiency and accuracy. Companies that can provide cost-effective and scalable automation solutions tailored to these markets are likely to capitalize on this demand. Additionally, the ongoing digital transformation in healthcare presents opportunities for the integration of cloud-based technologies and data analytics platforms, enabling laboratories to leverage automation for enhanced operational performance. As a result, the Industrial Automation in Life Sciences market is poised for robust growth as it embraces these opportunities for innovation and expansion.

Threats

Despite the promising growth trajectory of the Industrial Automation in Life Sciences market, several threats could hinder its progress. One significant concern is the rapid pace of technological advancement, which can render existing systems obsolete. As new technologies emerge, laboratories may face challenges in keeping up with the latest innovations and integrating them into their existing workflows. This creates pressure to continuously invest in updating and upgrading automation systems, which can be a financial burden for smaller laboratories. Moreover, the market is facing a competitive landscape where numerous players are vying for market share, leading to price wars and potentially compromising product quality. Manufacturers must balance the need to offer competitive pricing with the requirement to maintain high-quality standards, which can create challenges in sustaining profitability.

Another notable threat is the increasing regulatory scrutiny in the life sciences sector. As automation technologies advance, regulatory bodies are imposing stringent guidelines to ensure safety, efficacy, and data integrity. Navigating these regulatory requirements can be complex and costly for manufacturers and laboratories alike. Non-compliance can result in significant penalties and damage to reputation, thus posing a considerable risk. Additionally, the market is susceptible to economic fluctuations, which can impact research funding and investment in new technologies. Economic downturns may lead to reduced budgets for research and development, ultimately affecting the demand for industrial automation solutions. Companies must remain vigilant and adaptable to mitigate these threats and ensure sustainable growth in the market.

The restrainer of the Industrial Automation in Life Sciences market primarily revolves around the high initial investment required for implementing automation solutions. Many laboratories, particularly smaller ones, may be hesitant to adopt automation due to the substantial upfront costs associated with purchasing and integrating advanced systems. This financial barrier can limit the market's overall growth potential as these organizations may opt to stick with traditional manual processes instead. Consequently, manufacturers must focus on developing cost-effective solutions and flexible financing options to encourage adoption. Additionally, the complexity of integrating automation systems with existing infrastructure can also pose challenges, as laboratories may require extensive training and support to ensure successful implementation. Addressing these restraints is essential for unlocking the full potential of the Industrial Automation in Life Sciences market.

Competitor Outlook

• Thermo Fisher Scientific
• Abbott Laboratories
• Beckman Coulter
• Agilent Technologies
• Siemens Healthineers
• PerkinElmer
• Roche Diagnostics
• GE Healthcare
• Zymergen
• Bio-Rad Laboratories
• Illumina
• Hitachi High-Technologies
• LabCorp
• Waters Corporation
• Qiagen

The competitive landscape of the Industrial Automation in Life Sciences market is characterized by a diverse array of players, ranging from established multinational corporations to innovative startups. Major companies such as Thermo Fisher Scientific and Abbott Laboratories are at the forefront, leveraging their extensive expertise and resources to develop cutting-edge automation solutions. These firms employ a comprehensive approach, integrating advanced technologies such as robotics, AI, and machine learning into their product offerings. The competitive environment is marked by continuous innovation, as companies strive to enhance laboratory efficiency, accuracy, and productivity while addressing the evolving needs of life sciences research. In this rapidly changing landscape, collaboration and partnerships between technology providers and research institutions are becoming increasingly important to foster innovation and drive market growth.

Thermo Fisher Scientific, a global leader in laboratory equipment and automation solutions, offers a wide range of products tailored to the life sciences sector. With a strong emphasis on research and development, the company is continuously innovating its automation technologies to meet the demands of modern laboratories. Their solutions, which include automated liquid handling systems and integrated laboratory workflows, cater to various applications, such as drug discovery and clinical diagnostics. Abbott Laboratories, another prominent player, focuses on developing innovative automated solutions for diagnostics and research applications. Their commitment to enhancing laboratory efficiency and accuracy has positioned them as a key competitor in the market.

Other notable companies such as Beckman Coulter and Agilent Technologies also play significant roles in shaping the competitive landscape. Beckman Coulter specializes in laboratory instrumentation and automation solutions, providing comprehensive systems that streamline laboratory workflows. Their extensive experience in clinical diagnostics and research applications enables them to address the specific needs of laboratories effectively. Agilent Technologies, on the other hand, focuses on analytical solutions, offering automation technologies that enhance the capabilities of laboratories in genomics, proteomics, and drug discovery. As the market evolves, these companies will continue to adapt their strategies to remain competitive and drive innovation within the Industrial Automation in Life Sciences market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Qiagen
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 LabCorp
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Illumina
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zymergen
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 GE Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Beckman Coulter
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Waters Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Siemens Healthineers
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hitachi High-Technologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Industrial Automation in Life Sciences Market, By Application
    • 6.1.1 Drug Discovery
    • 6.1.2 Clinical Diagnostics
    • 6.1.3 Genomics
    • 6.1.4 Proteomics
    • 6.1.5 Others
  • 6.2 Industrial Automation in Life Sciences Market, By Product Type
    • 6.2.1 Automated Liquid Handling Systems
    • 6.2.2 Robotics and Machine Learning Systems
    • 6.2.3 Automated Microplate Readers
    • 6.2.4 Automated Storage and Retrieval Systems
    • 6.2.5 Others
  • 6.3 Industrial Automation in Life Sciences Market, By Ingredient Type
    • 6.3.1 Hardware
    • 6.3.2 Software
    • 6.3.3 Services
  • 6.4 Industrial Automation in Life Sciences Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Industrial Automation in Life Sciences Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Industrial Automation in Life Sciences market is categorized based on

By Product Type

• Automated Liquid Handling Systems
• Robotics and Machine Learning Systems
• Automated Microplate Readers
• Automated Storage and Retrieval Systems
• Others

By Application

• Drug Discovery
• Clinical Diagnostics
• Genomics
• Proteomics
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Ingredient Type

• Hardware
• Software
• Services

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Abbott Laboratories
• Beckman Coulter
• Agilent Technologies
• Siemens Healthineers
• PerkinElmer
• Roche Diagnostics
• GE Healthcare
• Zymergen
• Bio-Rad Laboratories
• Illumina
• Hitachi High-Technologies
• LabCorp
• Waters Corporation
• Qiagen